Invite a friend to get their first reward.Claim 1000 Satoshis

I'm searching

For Hoomans

You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.

Alogliptin-Pioglitazone

Alogliptin-Pioglitazone is a combination medication used to manage type 2 diabetes mellitus. It combines two active ingredients: alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and pioglitazone, a thiazolidinedione (TZD). This combination helps to improve blood sugar control in adults when diet and exercise alone are insufficient. Alogliptin increases insulin release and decreases glucose production in the liver, while pioglitazone improves insulin sensitivity in peripheral tissues.

Rx. Enter your prescription

How would you like to get your prescription? Select an option

Pharmacy pickup

Select from 35,000 pharmacies

Free two-day delivery

Coming soon!

Find a pharmacy near you. Enter your ZIP code

Please enter your ZIP to find pharmacies near you.

Are you a member? Sign up or log in.

Sign up for free to start earning Bitcoin rewards

Get your personal savings card. Watch your Bitcoin balance grow and get paid whenever you want.

Sign Up

Access my personal savings card

Get instant savings at my pick-up pharmacy and earn bitcoin in my NiHowdy account

Log In
backgroundbackground

Members have saved

$NaN

using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!

NaNM

worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.

How much Bitcoin can you earn with Alogliptin-Pioglitazone ?

The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.

See the value of your savings today

Today's Value

Bitcoin1 Bitcoin = $NaN

Bitcoin (BTC)

...

USD

$NaN

Adjust Bitcoin's potential value to see how much it could be worth

Potential Value

Bitcoin1 Bitcoin =

Bitcoin (BTC)

...

USD

$NaN

Frequently Asked Questions

Can Alogliptin-Pioglitazone be taken with other diabetes medications?
Open FAQClose FAQ

Yes, Alogliptin-Pioglitazone can be used with other diabetes medications, such as insulin or sulfonylureas. However, careful monitoring for hypoglycemia is necessary, and dose adjustments may be required.

How should Alogliptin-Pioglitazone be stored?
Open FAQClose FAQ

Store Alogliptin-Pioglitazone at room temperature, away from moisture and light. Ensure that it is kept out of reach of children and pets.

Is Alogliptin-Pioglitazone safe during pregnancy?
Open FAQClose FAQ

There is limited data on the use of Alogliptin-Pioglitazone during pregnancy. It should only be used if the potential benefits outweigh the risks. Consult your healthcare provider for advice.

What should I do if I miss a dose of Alogliptin-Pioglitazone?
Open FAQClose FAQ

If you miss a dose, take it as soon as you remember, unless it is close to the time for your next dose. Do not double up on doses to make up for a missed one.

Comprehensive Drug Guide

How Does Alogliptin-Pioglitazone Work?

Alogliptin-Pioglitazone works through two complementary mechanisms. Alogliptin inhibits the enzyme DPP-4, prolonging the action of incretin hormones that increase insulin release and reduce glucagon levels in response to meals. Pioglitazone enhances insulin sensitivity in muscle and adipose tissue, allowing the body to use insulin more effectively. Together, these actions help to improve glycemic control in patients with type 2 diabetes.



Common Dosages

Alogliptin-Pioglitazone is commonly available in the following dosage combinations:

  • 12.5 mg/15 mg tablets (alogliptin/pioglitazone)
  • 12.5 mg/30 mg tablets (alogliptin/pioglitazone)
  • 12.5 mg/45 mg tablets (alogliptin/pioglitazone)


Typical Dosing


The typical dosing for Alogliptin-Pioglitazone is:

  • Adults: Start with 12.5 mg/15 mg, 12.5 mg/30 mg, or 12.5 mg/45 mg once daily, taken with or without food. The dosage may be adjusted based on glycemic control and tolerability.
  • Elderly: Dose adjustments may be required based on renal function and the patient's response.

Typical Dosing

FDA Approved Indications

Alogliptin-Pioglitazone is FDA-approved for the treatment of:

  • Type 2 diabetes mellitus, as an adjunct to diet and exercise to improve glycemic control in adults when single-agent therapy is insufficient.


Off-Label Uses

There are no widely recognized off-label uses for this combination medication.


Advice From The Pharmacist

Patients taking Alogliptin-Pioglitazone should:

  • Take the medication as prescribed, typically once daily with or without food.
  • Monitor blood sugar levels regularly and report any significant changes to their healthcare provider.
  • Be aware of the symptoms of heart failure (e.g., shortness of breath, rapid weight gain, swelling) and report them to a healthcare provider immediately.
  • Discuss all medications, supplements, and herbal products with their healthcare provider to avoid potential drug interactions.


Side Effects of Alogliptin-Pioglitazone

Common Side Effects

Common side effects of Alogliptin-Pioglitazone include:

  • Upper respiratory tract infection
  • Headache
  • Edema (swelling)
  • Weight gain


Uncommon/Severe Side Effects

Serious side effects may include:

  • Congestive heart failure (particularly with pioglitazone)
  • Bladder cancer (risk associated with pioglitazone)
  • Hepatotoxicity (liver injury)
  • Pancreatitis
  • Fractures, especially in women


Risks and Warnings of Alogliptin-Pioglitazone

Major risks and warnings associated with Alogliptin-Pioglitazone include:

  • Heart Failure: Pioglitazone may cause or exacerbate congestive heart failure. Patients should be monitored for signs of heart failure, and the drug should be discontinued if heart failure develops.
  • Bladder Cancer: Long-term use of pioglitazone has been associated with an increased risk of bladder cancer. The risk should be considered in patients with a history of bladder cancer.
  • Hepatic Impairment: Both alogliptin and pioglitazone have been associated with liver injury. Liver function tests should be performed before starting therapy and monitored periodically.
  • Fracture Risk: Pioglitazone may increase the risk of fractures, especially in women. Bone health should be monitored during treatment.

Interactions with Alogliptin-Pioglitazone

Common Drug Interactions

Alogliptin-Pioglitazone may interact with:

  • Insulin and Sulfonylureas: Increased risk of hypoglycemia. Dose adjustments may be needed.
  • CYP2C8 inhibitors (e.g., gemfibrozil): May increase pioglitazone levels, leading to a higher risk of side effects.
  • Rifampin: May reduce the effectiveness of pioglitazone by decreasing its blood levels.

Patients should maintain open communication with their healthcare provider regarding all medications, supplements, and herbal products they are taking.



Alternatives to Alogliptin-Pioglitazone

Alternative medications to Alogliptin-Pioglitazone include:

  • Sitagliptin-pioglitazone: A combination of a DPP-4 inhibitor and pioglitazone used for type 2 diabetes.
  • Sitagliptin-metformin (Janumet): Another combination of a DPP-4 inhibitor and metformin for managing blood sugar levels.
  • GLP-1 receptor agonists (e.g., liraglutide, exenatide): Another class of drugs that can be used with or instead of pioglitazone for glycemic control.